Author(s)

Manoj Kumar Sahu^*, Harsha Vardhan Niraghatam, Nikhil Bansal, Sarvesh Pal Singh, Palleti Rajashekar, Shiv Kumar Choudhary

Department of Cardiothoracic and Vascular Surgery, CN Centre, All India Institute of Medical Sciences, New Delhi, India.

Background: Junctional ectopic tachycardia (JET) is one troublesome supraventricular arrhythmia in postoperative pediatric cardiac surgical patients. Unless treated timely and effectively it may lead to morbidity and even mortality. Aim: To understand the role of Ivabradine in the treatment of JET in postoperative pediatric cardiac surgical patients. Case: We present a postoperative case of complete repair of Tetralogy of Fallot who was in normal sinus rhythm in the preoperative period and developed JET 4 hours later in postoperative period which was persistent despite measures to optimize the internal milieu of the body and conventional antiarrhythmics, that was successfully treated with Ivabradine at a dose of 0.05 mg/kg/12 hourly. Conclusion: Ivabradine can be used to successfully treat postoperative JET in cases ofrefractory to other antiarrhythmic drugs like Digoxin and Amiodarone.

Tetralogy of Fallot, Junctional Ectopic Tachycardia, Ivabradine

Sahu, M. , Niraghatam, H. , Bansal, N. , Singh, S. , Rajashekar, P. and Choudhary, S. (2019) Ivabradine—The Final Crusader for Postoperative Junctional Ectopic Tachycardia, a Case Report with Literature Review. World Journal of Cardiovascular Surgery, 9, 73-82. doi: 10.4236/wjcs.2019.98009.